Belgium (BE)

Analysis of sequence-defined oligomers through Advanced Polymer Chromatography™ - mass spectrometry hyphenation (2020) Berg MT, Mertens C, Du Prez F, Kühne TD, Herberg A, Kuckling D Journal article Promotion of mental health in young adults via mobile phone app: Study protocol of the ECoWeB (emotional competence for well-being in Young adults) cohort multiple randomised trials (2020) Newbold A, Warren FC, Taylor RS, Hulme C, Burnett S, Aas B, Botella C, et al. Journal article The role of Ti and TiC nanoprecipitates in radiation resistant austenitic steel: A nanoscale study (2020) Cautaerts N, Delville R, Stergar E, Pakarinen J, Verwerft M, Yang Y, Hofer C, et al. Journal article Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function (2020) Wuyts WA, Azuma A, Distler J, Sondergaard K, Proudman S, Cottin V, Erhardt E, et al. Conference contribution Do surgical skills affect outcomes? (2020) Tou S, Gomez Ruiz M, Gallagher AG, Eardley NJ, Matzel K Journal article Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution Efficacy and safety of lanreotide autogel (LAN) 120 mg every 14 days in progressive pancreatic or midgut neuroendocrine tumours (NETs): CLARINET FORTE study results (2020) Pavel ME, Cwikla JB, Lombard-Bohas C, Borbath I, Shah T, Pape UF, Thanh XMT, et al. Conference contribution Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2,-3, and-7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptore-positive, HER2-negative (HR+/HER2L) advanced breast cancer (ABC) (2020) Fasching P, Bardia A, Nusch A, Jerusalem G, Chan A, El Saghir N, Alba E, et al. Conference contribution Dissecting the mechanism of action of intravenous immunoglobulin in human autoimmune disease: Lessons from therapeutic modalities targeting Fcγ receptors (2020) Shock A, Humphreys D, Nimmerjahn F Journal article